In Veritas Medical Stock Today
| IVME Stock | USD 0.0001 0.00 0.00% |
PerformanceVery Weak
| Odds Of DistressDangerous
|
In Veritas is trading at 1.0E-4 as of the 27th of February 2025, a No Change since the beginning of the trading day. The stock's lowest day price was 1.0E-4. In Veritas has a very high chance of experiencing financial distress in the next few years of operation. It has also generated negative returns for investors over the last 90 days. The performance scores are derived for the period starting the 28th of January 2025 and ending today, the 27th of February 2025. Click here to learn more.
Business Domain Financial Services | Classification Financials |
In Veritas Medical Diagnostics, Inc., a development stage company, engages in the research and development of medical devices with near-patient testing applications. It was formerly known as In Vivo Medical Diagnostics, Inc. and changed its name to In Veritas Medical Diagnostics, Inc. The company has 86.05 M outstanding shares. More on In Veritas Medical
Follow Valuation Profit Patterns Odds of Bankruptcy
Check how we calculate scores
IVME Stock Highlights
| Business Concentration | Asset Management & Custody Banks, Financial Services, Financials, Capital Markets, Shell Companies, Financial Services (View all Sectors) | |||||||||||||||||||||||||||||||||||||||||||||||||||||||
Financial Strength
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
In Veritas Medical (IVME) is traded on OTCCE Exchange in USA and employs 7 people. In Veritas is listed under Asset Management & Custody Banks category by Fama And French industry classification. The company currently falls under 'Nano-Cap' category with a current market capitalization of 8.61 K. In Veritas Medical conducts business under Capital Markets sector and is part of Financials industry. The entity has 86.05 M outstanding shares.
In Veritas generates negative cash flow from operations
Check In Veritas Probability Of Bankruptcy
IVME Stock Against Markets
Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in In Veritas Medical. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in population. You can also try the Commodity Channel module to use Commodity Channel Index to analyze current equity momentum.
Is Asset Management & Custody Banks space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of In Veritas. If investors know IVME will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about In Veritas listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of In Veritas Medical is measured differently than its book value, which is the value of IVME that is recorded on the company's balance sheet. Investors also form their own opinion of In Veritas' value that differs from its market value or its book value, called intrinsic value, which is In Veritas' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because In Veritas' market value can be influenced by many factors that don't directly affect In Veritas' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between In Veritas' value and its price as these two are different measures arrived at by different means. Investors typically determine if In Veritas is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, In Veritas' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.